Science Advances

Supplementary Materials

This PDF file includes:

  • Fig. S1. HPAC strongly binds to HSV-1 GFP virus.
  • Fig. S2. Extracellular virus–based plaque assay for HPAC therapy.
  • Fig. S3. HPAC does not cause a loss in visual acuity by blocking light.
  • Fig. S4. HPAC does not elevate interferons in HCEs.
  • Fig. S5. HPAC does not elevate interferons in HFFs.
  • Fig. S6. DECON is effective when added 24 hours after infection.
  • Fig. S7. DECON protects the murine cornea from HSV-1 infection.
  • Fig. S8. Graphical abstract showing DECON protecting cells against viral infection.
  • Fig. S9. Full-length blots for the Western blot shown in Fig. 1 (G and H).
  • Fig. S10. Full-length blots for the Western blot shown in Fig. 3D.

Download PDF

Files in this Data Supplement: